OptiZone
OptiZone is a Swiss sports tech platform, spun out of EPFL, that pairs IMU sensors with a mobile app and a web dashboard so professional clubs and academies can assess performance, estimate injury risk and protect player availability.
What is OptiZone?
OptiZone is a sports technology platform published by OptiZone SA, a Swiss company registered on 20 November 2025 and based at the EPFL Innovation Park, Building C, in Lausanne. It presents itself as Swiss sports tech and an EPFL spin-off, and its stated purpose is to make laboratory-grade biomechanics usable at the side of the pitch.
What is sold is a chain rather than a piece of software: professional IMU sensors, straps and a tablet on the field, a mobile app for capture, and a web dashboard for interpretation. Work follows four steps, measure, connect, understand and act, matched by four modules.
AssessME covers field assessment: jumps, changes of direction and sprints, with force and movement analysed together to surface ACL strain, hamstring strain, knee valgus and knee moments. AlignME merges outside sources, GPS, VALD, isokinetic testing, strength, mobility and match data, and looks for gaps between the load a player carries and the capacity that player has. AskME is a conversational AI agent over those data: questions are typed in French, English or Spanish and answers come back as charts, rankings, scatter plots or load calendars. AlertME turns the result into a prioritised watchlist, PRIORITY or WATCH, with the causes behind each flag and a checklist of actions, weighted by the rules the staff defines. Five roles are addressed explicitly: sporting management, head coach, physical preparation, physiotherapy and medicine.
The evidence should be read as what it is, the publisher's own claims. The site states 94% accuracy against laboratory measurement, a three-minute field protocol, deployment in one day and more than 1,850 professional athletes tested. It describes validation in a FIFA Medical Center of Excellence and a three-year longitudinal study on a cohort of over 1,550 professional players, in which 78% of non-contact ACL ruptures were predicted, 28 out of 35. The model's top-ranked variables are given as previous injury and its severity, quadriceps-to-hamstring ratio asymmetry, dynamic knee valgus on landing and Reactive Strength Index asymmetry. A 2024-2025 case-control study across four teams and five high-risk players is also cited. None of these figures is tied to a named publication, a DOI or a link.
What it does
- Run a biomechanical assessment on the pitch in about three minutes, with no laboratory
- Estimate non-contact injury risk, in particular ACL strain, hamstring strain and knee valgus load
- Merge GPS, VALD, isokinetic, strength and mobility data into a single player view
- Query the data in plain language and get charts, rankings and load calendars in return
- Obtain a prioritised list of players to watch, with identified causes and concrete actions
- Track rehabilitation progress objectively and frame return-to-play decisions
When to use OptiZone / When not to
A quick filter to help you decide if OptiZone is the right fit.
When to use OptiZone
- Professional clubs that need a live read on squad availability and a shared reference point for technical and medical staff
- Youth academies tracking the long-term development of young players across successive seasons
- Medical and physiotherapy staff looking for functional benchmarks during rehabilitation and progressive return to play
- Heads of performance who want tests, asymmetries, fatigue and risk profiles connected to training decisions, with GPS, VALD and isokinetic data brought together
- Teams with no access to a biomechanics laboratory, since the assessment runs on the pitch in about three minutes
When not to use OptiZone
- Buyers who expect a self-service purchase: the only route in is a demo request, with no published pricing and no announced free plan
- Developers who need an API: no public API and no API documentation could be found
- Staff who want to download the app from the App Store or Google Play, as no application is published on either store even though a mobile app ships with the kit
- Organisations whose procurement requires published legal documentation, since no privacy policy, terms of service, legal notice or DPA is available, and no ISO or SOC 2 certification is claimed
- Amateur and individual athletes: the product is built for elite team sport, football above all, and no medical device status is claimed
How to use OptiZone
A typical end-to-end flow, from setup to results.
- Request a demo through the site's form, giving full name, work email, organisation, role and main need
- Attend the 30-minute demo, adapted to the club's sport, staff and current priorities, in four steps: opening discussion, platform walkthrough, practical use cases, next steps
- Deploy the kit of IMU sensors, straps and tablet, which the site announces at one day with no heavy IT project at the outset
- Take the portable kit onto the pitch, into the gym or into the rehabilitation room
- Run the guided AssessME protocol, around three minutes per player, while the app records the movement without disrupting the session
- Read the immediate report on force, movement and risk indicators
- Connect AlignME to the club's existing sources, GPS, VALD, isokinetic testing, mobility and match data, for one login and a complete player view
- Set AlertME's rules and context, since a team doctor and a strength coach do not share the same priorities
- Ask AskME questions in written French, English or Spanish rather than building a dashboard or exporting a file
- Work from the dashboard day to day: player profiles, analyses, trends, alerts and the actions attached to them
Pros & Cons
Pros
- Biomechanical assessment without a laboratory, on a field protocol announced at three minutes per player
- The scientific grounding is set out unusually explicitly: a FIFA Medical Center of Excellence setting, a three-year longitudinal study on more than 1,550 professional players and a claimed 94% accuracy against laboratory references
- Multi-source fusion removes the need to move between VALD, GPS and isokinetic tools to read one player
- Natural language querying means no dashboard has to be built and no file exported
- Outputs are shaped by role, so technical and medical staff can use them as they come
- The operational team and the scientific advisory board are named and verifiable, with EPFL, CHUV, Swiss Olympic and FIFA connections
- Deployment is announced at one day with no heavy IT project, and the company is backed by a dense innovation ecosystem including Innosuisse, Venture Kick, FIT, Innovaud, EPFL Startup Launchpad, Platinn, MIT DesignX and PERL
Cons
- No public pricing of any kind: the cost cannot be estimated without going through a demo
- No privacy policy, terms of service or legal notice is published, even though the tool handles athletes' biomechanical and health data
- No data processing agreement and no list of sub-processors
- No public API, and no application published on the App Store or Google Play despite a mobile app forming part of the kit
- A very young legal entity: OptiZone SA was registered on 20 November 2025
- The site is a published redesign served from a /website/ directory, with a "Students & Interns" section left as an unedited template and a stale sitemap.xml whose 30 URLs all return 404
- Performance figures are attached to no named scientific publication, no DOI and no reference, and no certification (ISO, SOC 2) or medical device status is claimed
Pricing & Plans
OptiZone publishes no product pricing. No rate card, no plan and no entry price appears anywhere: a pricing page was probed across the five language directories, along with 110 equivalent paths, and every one returned 404 against a discriminating control, while a search of the archived corpus for currency and billing terms returned no product price. No free plan and no free trial is announced, and neither is explicitly ruled out. Access is commercial only: the single route in is a demo request, after which terms are agreed case by case, which places the tool in a contact-sales model. One monetary figure does appear on the site, CHF 1 million secured through innovation awards and programmes, but that is company funding rather than a product price and must not be read as a rate. Prospective buyers should expect to obtain a quotation directly from the publisher.
Data, GDPR & hosting
A consolidated view of how OptiZone handles your data.
GDPR overview
The site makes no reference to the GDPR. A search of the whole archived corpus returned zero occurrences of GDPR, RGPD, DSGVO, privacy policy or personal data. No EU representative under Article 27 is named, no data protection officer is identified, and the only published address is the generic info@optizone.ch. There is accordingly no claim of compliance and no denial of one: the subject is simply absent. Context matters. OptiZone SA is Swiss and Switzerland sits outside the EU, so the revised Swiss Federal Act on Data Protection applies domestically while the GDPR would apply extraterritorially to any European club served. The clinical partners displayed (CHUV, HUG) and the European club setting both imply health data. A prospective buyer should expect to obtain the entire data protection framework contractually, because none of it is published.
Who owns the data?
No contractual document published by OptiZone addresses ownership of the data. At the date of review the site carries no terms of service, no privacy policy, no legal notice and no data processing agreement: 110 candidate legal paths were probed across the site's five language directories and every one returned 404 against a discriminating control. Who owns the biomechanical and health data captured on players, and what the publisher may do with it or share with whom, is therefore defined nowhere in public. The only related sentence sits under the demo form, "We use this information only to prepare your OptiZone discussion", and it covers the contact details typed into that form, not athlete data.
Reuse rights
Nothing on the site sets out what either party may do with the data. With no terms of service and no privacy policy published, there is no licence, no stated reuse permission and no restriction that a customer could rely on; any right to export, reuse or share the data would have to be negotiated in the contract that follows a demo. The product itself handles jumps, changes of direction, sprints, force and movement measurements, GPS, isokinetic testing, VALD data, mobility, match data, calendar, playing position and injury history. Separately, the demo form collects full name, work email, organisation, role and main need, and posts them to a Google Apps Script endpoint. Whether customer data is used to train models is never addressed either way.
Data retention & training
Hosting summary
OptiZone publishes no data hosting information. No country, region, cloud provider or data centre is named anywhere on the site, and there is neither a privacy policy nor a security page where such a statement would normally sit; a search of the archived corpus for hosting terms returned nothing at all. One fact was measured, and it concerns only the marketing website rather than the platform that would hold player data: optizone.ch resolves to 20.199.136.27, an address operated by Microsoft in Zurich, Switzerland, with no anycast indicator. The domain registrar is Hostpoint AG, based in Rapperswil-Jona, Switzerland. Both point to Swiss infrastructure for the public site. That must not be read as a statement about the product. Nothing establishes where assessments, player profiles, health data or the AI layer are processed or stored, nor under which jurisdiction, nor whether any transfer takes place. A club subject to the GDPR, or to Swiss health data rules, should obtain the hosting location, the sub-processor list and the transfer mechanism in writing before the first capture.
Things to keep in mind
Risks and trade-offs to weigh before adopting OptiZone.
- No legal document is published at all: no privacy policy, no terms of service, no legal notice and no data processing agreement. The absence was established by probing 110 paths across five language directories against a discriminating 404 control, and it concerns a tool that handles athletes' biomechanical and health data.
- The demo form sends full name, work email, organisation and role to a Google Apps Script endpoint (script.google.com/macros/s/.../exec) without any information on that processing being given to the person filling it in. This de facto sub-processor is not declared anywhere.
- The performance figures (94%, 78%, 28 out of 35, more than 1,550 players, more than 1,850 athletes tested) are site claims with no named scientific publication, no DOI and no link behind them. Note also an internal discrepancy: the home page announces "1,850+ pro athletes tested" for AssessME while the science section refers to "1,550+ professional players" as the study cohort. These are two different measures and should not be conflated.
- The 2024-2025 case-control study covers four teams and five high-risk players: two in the control group, both of whom ruptured an ACL, and three in the intervention group, with no serious injury. The sample is very small and the result should be read with caution.
- The logos on display (FIFA, CHUV, HUG, Swiss Olympic, EPFL) identify partners and validation settings, not certifications held by the publisher. No certification is claimed and no medical device status is held: the outputs support the staff's decision, they do not replace it.
- The site is a published redesign in progress. Everything is served from a /website/ directory whose index is titled "OptiZone - Website redesign" and offers a choice of site version in French and English only, while the apex redirects to /website/en/index.html. The "Students & Interns" section is still an unedited template, showing its instruction to the editor in public, "Seven profiles are ready to be completed. You can replace the photo, name, role, description and logo when the information is available", alongside cards reading "Role to be completed", "LOGO TO ADD" and "PHOTO". French development notes remain in the public HTML and the sitemap.xml is stale, with all 30 of its URLs returning 404. Content may change quickly.
- The project predates the legal entity: the optizone.ch domain has been registered since 3 December 2024 and the first Internet Archive capture dates from 31 July 2025, both before OptiZone SA was entered in the commercial register on 20 November 2025. Note also a naming difference: the register lists the board as Mina Arabbaniasad (chair), Farzin Dadashi and Golnaz Borghei, while the site names them Mina Baniasad, Feri Dadashi and Golnaz Borghei.
Setup & Integrations
Technical difficulty
Low, on the publisher's own account. Deployment is announced at one day and without complex integration, and the demo FAQ states that no heavy IT project is required at the outset. The physical side is a portable kit of IMU sensors, straps and a tablet, set up quickly and designed for the real pace of a club. The field protocol runs in three minutes per player without disturbing the session. AlignME gathers existing sources through one connection, and AskME removes dashboard building and file exports. No specific technical skill is stated as necessary.
Deployment
Integrations
Supported languages
Behind OptiZone
Resources
All the official URLs gathered for verification and reference.
Frequently asked questions
How long does an OptiZone assessment take?
What evidence supports the injury risk model?
Which data sources can be connected?
In which languages can the AI assistant be queried?
Is there an API?
Is there a mobile app on the App Store or Google Play?
How much does OptiZone cost?
Does OptiZone require a heavy IT integration, and how does a demo work?
Who publishes OptiZone?
Does the site publish a privacy policy?
Should you pick OptiZone?
OptiZone has an unusually well-defined proposition: take the biomechanics that normally require a laboratory and make them usable at the side of the pitch, in about three minutes per player, then connect the result to everything else the club already measures. The four modules follow that logic cleanly, from field capture through data fusion to a prioritised watchlist, and the natural language layer removes the dashboard-building step that usually stalls tools of this kind.
The scientific grounding is stated more explicitly than is common for a young company: EPFL origins, CHUV and HUG clinical partners, Swiss Olympic, a FIFA Medical Center of Excellence setting, a named team and a named scientific advisory board. That is a real differentiator, with one caveat: the headline figures, 94% accuracy, 78% of non-contact ACL ruptures predicted, 28 out of 35, cohorts of 1,550 and 1,850, are the publisher's claims and are attached to no named publication, DOI or link.
Against that sit real gaps. OptiZone SA was registered on 20 November 2025 and the shop window is still under construction: the whole site is served from a redesign directory, one section remains an unedited template, and the sitemap is stale. More seriously, no legal document is published at all, no privacy policy, no terms, no legal notice, no data processing agreement, for a product that processes athletes' biomechanical and health data. Cost cannot be assessed without contacting sales.
For a professional club or academy the platform is worth a demo, on condition that the data protection framework and the evidence base are both put in writing during procurement rather than taken from the website as it stands.
- Choosing a selection results in a full page refresh.
- Opens in a new window.